Equity · Healthcare
ASTH
NASDAQAstrana Health (ASTH)
The line runs 37.73 USD on 13 August through 32.17 USD on 10 November, on a scale from 30 to 45. Days the market did not trade hold the previous close, flat.
- Market cap
- 1.8B USD
- P/E (TTM)
- 30.1
- Revenue, year to Dec 2025
- 3.2B USD
- EPS, diluted, year to Dec 2025
- 0.46 USD
- 52-week range
- 18.14 USD – 49.81 USD
- Avg volume
- 19.2K
as of Nov 10, 2026
Have Astrana Health (ASTH) insiders bought or sold shares recently?
In the 90 days to 11 Nov 2026, no Astrana Health insider bought or sold shares on the open market; all 10 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 11 Nov 2026, newest Form 4 filing 10 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 10 Oct 2026 | Vong JohnSVP - Accounting (PAO) | Tax withheld | 556 | 21K USD |
| 06 Oct 2026 | Sim BrandonCEO and President | Tax withheld | 9,889 | 366K USD |
| 06 Oct 2026 | Lam Thomas S.Director | Tax withheld | 2,624 | 97K USD |
| 02 Oct 2026 | Basho ChandanCOO and CFO | Tax withheld | 2,092 | 75K USD |
| 15 Sep 2026 | Vong JohnSVP - Accounting (PAO) | Tax withheld | 96 | 4K USD |
| 05 Sep 2026 | Sim BrandonCEO and President | Tax withheld | 7,163 | 276K USD |
| 05 Sep 2026 | Basho ChandanCOO and CFO | Tax withheld | 1,790 | 69K USD |
| 31 Aug 2026 | Kitayama Mitchell WDirector | Other | 8,500 | 315K USD |
| 14 Aug 2026 | Schmidt DavidDirector | Option exercise | 20,000 | 100K USD |
| 14 Aug 2026 | Schmidt DavidDirector | Other | 20,000 | 772K USD |
Which funds hold Astrana Health (ASTH)?
5 of the 45 institutional funds we track reported a Astrana Health position for the quarter ended 30 Jun 2026 — a combined 15.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Added | 190,503 | 8.8M USD | +1,122.1% |
| Renaissance Technologies | Trimmed | 74,646 | 3.5M USD | −28.6% |
| Citadel Advisors | Held (±25%) | 25,069 | 1.2M USD | +0.2% |
| Man Group | Trimmed | 18,639 | 865K USD | −87.8% |
| AQR Capital Management | Trimmed | 17,628 | 818K USD | −48.7% |
| Balyasny Asset Management | Exited |
Have members of Congress traded Astrana Health (ASTH)?
The most recent congressional trade disclosed in Astrana Health is a sale by Judy Chu (house, CA), dated 19 Aug 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 19 Aug 2025 | Judy Chuhouse · Democrat–CA | Sale | 100K USD–250K USD | 11 days |
What has been filed or recorded for Astrana Health (ASTH)?
The filings we hold for Astrana Health, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 5,979 shares | 226K USD notional · 0.011% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 572 shares | 21K USD notional · 0.001% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 51 shares | 2K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.26 USD | |
| 30 Sep 2026 | Financials | Total assets | 2.3B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 856.6M USD | at period end |
| 29 Sep 2026 | Fails to deliver | Shares failed to deliver | 2,319 shares | 81K USD notional · 0.004% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.40 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2025 reported | EPS 0.29 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.46 USD | |
| 31 Dec 2025 | Financials | Revenue | 3.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 22.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.46 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.01 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.19 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.14 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.90 USD |
What do people ask about Astrana Health (ASTH)?
What did Astrana Health shares close at?32.17
Astrana Health closed at 32.17 USD on 10 Nov 2026, down 4.74% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Astrana Health’s market cap?1.8B
Astrana Health is worth 1.8B USD by market value as of 10 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Astrana Health’s P/E ratio?30.1
Astrana Health has a price-to-earnings ratio of 30.1, as of 10 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Astrana Health’s revenue?3.2B
Astrana Health reported revenue of 3.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Astrana Health insiders bought or sold shares recently?10 filings
In the 90 days to 11 Nov 2026, no Astrana Health insider bought or sold shares on the open market; all 10 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Astrana Health?5 of 45
5 of the 45 funds we track reported a Astrana Health position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, Renaissance Technologies and Citadel Advisors. See Funds
Have members of Congress traded Astrana Health?1 trade
Yes. 1 trade in Astrana Health appears in the congressional disclosures we hold: a sale by Judy Chu (House, CA) dated 19 Aug 2025, filed 30 Aug 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Astrana Health last report earnings?0.26
Astrana Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.26 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Judy Chu: Online Guide to House Members and Senators, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings